Spindle cell oncocytoma (SCO) of the adenohypophysis is an extremely rare sellar-region tumor that creates clinicopathologically relevant problems in the differential diagnosis and difficulties in patient management due to the limited data available regarding its biological behavior. A sellar/suprasellar mass was detected and surgery was performed in a 61-year-old male admitted for impaired vision. The patient was re-operated on twice due to persistence of symptoms and an increase in tumor size at the third and sixth postoperative month. The histopathological examination revealed tumor cells with oncocytic cytoplasm and spindleepithelioid morphology fascicles/layers/pseudoacinar structures. Neoplastic cells showed a positive immunoreactivity with vimentin, epithelial membrane antigen, galectin 3, thyroid transcription factor-1, and anti-mitochondrial antibodies, and a negative immunoreactivity with epithelial markers, pituitary hormones, and neuroendocrine markers. Compared with the first biopsy sample, the material obtained from recurrent lesions was histologically characterized by increased pleomorphism, atypia, and mitotic activity. Although SCO is defined as Grade I according to the current World Health Organization classification, the considerable risk of early recurrence should be taken into account, especially in cases with atypiapleomorphism and increased mytotic activity.
INTRODUCTION
Spindle cell oncocytoma (SCO) of the anterior pituitary is an extremely rare pituitary tumor. First defined by Roncaroli et al., [1] this tumor was recognized by the World Health Organization (WHO) 2007 classification as a separate entity from other tumors of sellar origin. [2] To date, approximately 26 cases have been reported, with the largest series involving 5 cases. This tumor was first regarded as WHO Grade I, since the initial cases exhibited a benign morphology with no recurrence. [2] Recently, however, cases with local recurrence and atypical morphology have been reported.
In this study, the clinical and histopathological properties an SCO case with local recurrences and atypical morphology are discussed and a review of the relevant literature is provided.
CASE REPORT

Clinical and radiological findings:
A 61-year-old man presented at the center with visual impairment that had begun 3 months earlier and progressed thereafter. An ophthalmological examination revealed bitemporal hemianopsia. A magnetic resonance imaging (MRI) examination showed a mass lesion 35x23x19 mm in size and internal cystic formations appearing isointense to gray matter on T1A and hyperintense to gray matter on T2A that filled the sellar/suprasellar region and compressed the optic chiasma inferiorly (Figs. 1-3 ). The hormone levels and other biochemical markers were within the normal limits. Based on the clinical and radiological findings, the patient was operated on for an initially diagnosed non-functional pituitary macroadenoma. The intraoperative examination revealed grayish-purple tumor tissue with a rich vascular supply invading the sellar floor and adjacent structures. The patient had persistent symptoms at the third and sixth month postoperatively, and was found to have an increased residual tumor size. A reoperation was performed. At the time of writing, 8 months after the third operation, he is now under close follow-up and no clinical/radiological recurrence has been observed.
Pathological examination:
Examination of the hematoxylin and eosin sections of all of the operative material showed tumoral lesions consisting of cells with an oncocytic appearance and spindle/epithelioid/polygonal morphology. The tumor cells had large, eosinophilic, granular cytoplasms, oval-round nuclei, and ill-defined solitary eosinophilic nucleoli. While the epitheloid/polygonal cells formed layers/pseudoacinar structures, the spindle tumor cells formed fascicular/storiform strings. Old and recent foci of bleeding were observed in the tumor tissue, which was rich in thin-walled vasculature. While there was no atypia in the first resection material, the material obtained from recurrent lesions exhibited moderate-severe pleomorphism. Mitotic activity was 0-1/10 high power fields (HPF) in the first resection material, 2-5/10 HPF in the second, and 5-6/10 HPF in the third. No atypical mitosis was observed. Dispersed aggregates of histiocytes with foamy cytoplasms and foci of focal mononuclear inflammation were present. No tissue of normal pituitary origin was visualized in any of the resection material. Staining with reticulin revealed solid islets and pseudoacinar structures surrounding cell groups with a Zellballen-like pattern (Fig. 4) .
Immnuohistochemical findings:
The tumor cells manifested diffuse vimentin (cytoplasmic), epithelial membrane antigen (EMA) (cytoplasmic, focal membranous), galectin 3 (cytoplasmic), thyroid transcription factor-1 (TTF-1) (nuclear), and anti-mitochondrial antibody (AMA) (cytoplasmic-granular) immunoreactivity. A few cell groups demonstrated a reaction with S100 protein, glial fibrillary acidic protein (GFAP), and synaptophysin. No reaction was evident with epithelial markers other than EMA, hypophyseal hormones, thyroglobulin, chromogranin, smooth muscle actin, and CD34. Based on the histopathological findings, the case was diagnosed as spindle cell oncocytoma (Fig. 5) . 
DISCUSSION
SCO is an extremely rare tumor with a prevalence of 0.1% to 0.4% among all sellar tumors. [2] According to the gender and age distribution characteristics of previously reported cases, the female/male ratio is 14/13 and the mean age at presentation is 56.4 years (range: 24-76 years). Approximately 60% of SCO cases present with impaired vision, while 50% manifest with panhypopituitarism, and 30% with headache. A majority of SCO cases receive a preoperative diagnosis of nonfunctional pituitary adenoma, and some cases are confused with other sellar tumors, such as schwannoma or craniopharyngioma. [2, 7, 23] Table 1 summarizes the SCO cases reported in the literature. The case reported here is that of a 61-year-old man whose disease manifested with bitemporal hemianopsia, which is the most common presenting symptom of SCO. The patient underwent surgery with an initial diagnosis of a pituitary macroadenoma.
In a meta-analysis performed by Covington et al., [7] all of the reported SCO cases were mass lesions of pituitary origin that showed intra-and suprasellar localization and invasion of the adjacent adenohypophysis. [7] In our case, the tumor filled the sellar region and extended to the suprasellar region. It had invaded the optic chiasma, left optic nerve, and both cavernous sinuses. Our findings suggest that an ill-bordered separation of the SCO lesion from the adjacent structures complicated its total resection and increased the risk of a residual/recurrent tumor. SCO is rich in cells and vasculature, but the tumor is usually accompanied by areas of acellular regression. This property gives the tumor a unique radiological appearance. Hasiloglu et al. [12] advocated that these MRI properties can be used in making the preoperative diagnosis.
SCO tends to form a relatively large mass lesion, with a reported average diameter of 27 mm (range: 1.8-60 mm).
Intraoperatively, it appears as a gelatinous mass that is grayish-cream in color, or in 50% of cases, as an elastic, purple, vascular mass. SCO has a thin wall and a rich vascular supply; thus, it may cause abundant bleeding that complicates complete resection. Our case had a tumor diameter of 35 mm and a tumor volume slightly above the reported average. In our case, a purple, vascular tumor mass was visualized intraoperatively, though no excessive hemorrhage took place.
SCO is composed of spindle cells forming fascicles and oncocytic epitheloid/polygonal cells forming layers/pseudoacinar structures. Cellular components usually appear monophasic, although some cases may have a striking biphasic appearance. The vascular stroma surrounding epitheloid/polygonal cell groups may form a Zellballen-like pattern with reticulin stain. Roncaroli et al. reported that this tumor may contain interstitial lymphocytic infiltration, hemosiderin laden macrophages, and areas of intratumoral hemorrhage. [21] Necrosis, however, is quite rare. A normal pituitary gland may rarely be located adjacent to the tumor. Vajtai [23, 24] and Yoshimoto [26] reported that SCO may contain follicle-like/rosette-like/ependymal areas of differentiation. In our case, the first resected material predominantly contained a spindle cell component, while the samples taken from recurrent lesions predominantly had epitheloid/polygonal cells, which notably form acinus-like organoid strings. The possibility that SCO contains areas of varying levels of differentiation may create difficulty for the pathology diagnosis; however, illustrating the typical histomorphological/immunohistochemical properties of the tumor may help in making the diagnosis.
SCO is thought to have a benign morphology and low proliferative activity. In recurrent cases, however, nuclear pleomorphism, mitotic activity, and the Ki-67 index may markedly increase. According to literature reports, recurrences may occur in lesions with both low and high Ki-67 indices, and lesions with a high Ki-67 index may reportedly have a greater rate of recurrence [4, 5, 9, 13, 21, 24] In our case, nucleomegaly and nuclear pleomorphism, albeit both focal, were prominent in the re-excision material compared with the initial biopsy sample. Additionally, mitotic activity and the Ki-67 index were markedly increased in the re-excision material. The early recurrence of our lesion may be related to the tumor's atypical morphology. However, studies with a larger number of patients are needed to fully clarify the effect of these properties on prognosis. The typical immunohistochemical profile of SCO is central for the differential diagnosis. Vimentin, EMA, TTF-1, and AMA immunopositivity is needed to make a positive diagnosis. Although galectin-3 positivity may occur in many cases, some researchers believe that this is artificial. S100 positivity was found in about 88% of cases reported in the literature, and synaptophysin positivity in 11%. In our case, the typical immunohistochemical profile of SCO was confirmed, and other diagnostic possibilities were ruled out with the help of an extensive immunopanel. Our case had focal GFAP and S-100 immunopositivity, which are not diagnostic for SCO, but have been reported at varying rates in the literature. [2, 8, 15, 19, [22] [23] [24] 26] Although no definitive information exists regarding the biological behavior of SCO, it is usually considered a lowgrade neoplasm that can be treated with surgery. Although total resection of a tumor is the gold standard treatment method, it is generally difficult to achieve that goal, since the tumor may invade normal pituitary gland and adjacent bony/soft tissues, and because it has a rich vascular supply. In most cases, residual/recurrent lesions were detected after the initial operation. Therefore, some researchers recommend close surveillance for early recurrrence. Some studies have reported recurrence despite total resection. [4, 5, 9, 13, 21, 24] Our case was characterized by 2 recurrences with rapid radiological growth in the first 6 months.
Clinically, radiologically, and histologically, the differential diagnosis of SCO comprises many neoplastic/non-neoplastic lesions of the sellar region. The most important among these are null cell adenoma, pituitocytoma, and granular cell tumor. Although these are the most important differential diagnoses of SCO, other histological differential diagnoses include other rare tumors of sellar origin, including intra/suprasellar oncocytic variant meningioma, oncocytic pituitary adenoma, craniopharyngioma, chordoma, choroid glioma, schwannoma, solitary fibrous tumor, paraganglioma, and metastatic lesions with oncocytic appearance. Since oncocytic meningioma, in particular, has a similar immunoprofile to SCO, demonstrating the dural connection significantly helps in distinguishing between them. [2, 15, 23, 26] Table 2 illustrates the clinical and pathological features of SCO and other sellar lesions.
In conclusion, SCO is an extremely rare sellar tumor that poses significant diagnostic difficulties. Although the typical immunohistochemical profile of the tumor significantly helps in the differential diagnosis, ultrastructural studies are recommended to make a definitive diagnosis. This tumor further complicates diagnosis by demonstrating follicle/acinus/rosette-like differentiations of varying patterns. Described as a Grade I tumor in the updated WHO classification, this tumor show early recurrence at significant rates; therefore, we believe that it would be prudent to monitor these lesions closely.
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